FIELD: chemistry.
SUBSTANCE: invention relates to organic chemistry and specifically to specific benzimidazole derivatives, structures of which are given below. Invention also relates to a pharmaceutical composition based on said benzimidazole derivative and use thereof. 
EFFECT: technical result is obtaining novel benzimidazole derivatives useful for treating or preventing a disease associated with ACC2.
5 cl, 10 tbl, 30 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIHYDROPYRAZOLOPYRAZINONE DERIVATIVE WITH MGAT-2 INHIBITORY ACTIVITY | 2020 |
|
RU2803743C2 |
| 6-MEMBERED HETEROCYCLIC DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | 2016 |
|
RU2683245C1 |
| NITROGEN-CONTAINING TRICYCLIC DERIVATIVES HAVING HIV REPLICATION INHIBITION ACTIVITY | 2016 |
|
RU2720145C2 |
| BICYCLIC NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS INCLUDING THEM | 2017 |
|
RU2753524C2 |
| SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUGS THEREOF | 2016 |
|
RU2712275C2 |
| NEW SULPHONAMIDE DERIVATIVES WITH SELECTIVE NOX INHIBITORY ACTIVITY | 2019 |
|
RU2809030C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUG THEREOF | 2017 |
|
RU2727962C1 |
| DRUG FOR INFLUENZA TREATMENT, CHARACTERIZED BY THE FACT THAT IT COMBINES A PER-DEPENDENT ENDONUCLEASE INHIBITOR AND A DRUG AGAINST FLU | 2016 |
|
RU2745071C2 |
| NUCLEIC ACID DERIVATIVE EXHIBITING IMMUNOSTIMULATING ACTIVITY | 2016 |
|
RU2730871C1 |
| CONDENSED CYCLIC DERIVATIVE WITH INHIBITORY ACTIVITY AGAINST MGAT-2 | 2018 |
|
RU2770437C2 |
